1. CRISPR infusion eliminates swelling in those with rare genetic disease  Science
2. Intellia Investors Are Dumping Stock on News of Crispr Gene-Editing Success  Barron's
3. Intellia's gene editing therapies both post early successes as evidence grows for CRISPR potential  FierceBiotech
4. Intellia says CRISPR treatment safely corrects DNA of six patients with rare disease  STAT
5. Intellia offers first look at CRISPR drug for rare swelling disorder  BioPharma Dive
6. View Full Coverage on Google News

More here:
CRISPR infusion eliminates swelling in those with rare genetic disease - Science

Comments are closed.